BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 6957368)

  • 21. Significance of plasma fibrinopeptide A (fpA) in patients with malignancy.
    Peuscher FW; Cleton FJ; Armstrong L; Stoepman-van Dalen EA; van Mourik JA; van Aken WG
    J Lab Clin Med; 1980 Jul; 96(1):5-14. PubMed ID: 7391657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibrinopeptide A and the phosphate content of fibrinogen in venous thromboembolism and disseminated intravascular coagulation.
    Leeksma OC; Meijer-Huizinga F; Stoepman-van Dalen EA; van Ginkel CJ; van Aken WG; van Mourik JA
    Blood; 1986 May; 67(5):1460-7. PubMed ID: 3697510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A method for the assay of fibrinopeptide in plasma].
    Piana A; Armani U; Saccarello A; Boeri D; Maiello M; Falzetti G
    Boll Soc Ital Biol Sper; 1983 Oct; 59(10):1558-61. PubMed ID: 6661319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibrinopeptide A in acute leukemia: relationship of activation of blood coagulation to disease activity.
    Myers TJ; Rickles FR; Barb C; Cronlund M
    Blood; 1981 Mar; 57(3):518-25. PubMed ID: 6936055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subclinical activation of fibrinolysis in atherosclerotic disease detected by B beta 15-42 assay.
    Marongiu F; Mamusa AM; Mameli G; Conti M; Sorano GG; Biondi G; Farci P; Balestrieri A
    Ric Clin Lab; 1989; 19(2):157-63. PubMed ID: 2528202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo measurements of fibrin formation and fibrinolysis in operable breast cancer.
    McCulloch P; Douglas J; Lowe GD; Murray G; George WD
    Thromb Haemost; 1989 Apr; 61(2):318-21. PubMed ID: 2749603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activity.
    Nossel HL; Ti M; Kaplan KL; Spanondis K; Soland T; Butler VP
    J Clin Invest; 1976 Nov; 58(5):1136-44. PubMed ID: 993337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Beta-thromboglobulin and fibrinopeptide A in acute myocardial infarction].
    Cassetti M; Palazzesi G; Materazzi M; Massoli PD
    Quad Sclavo Diagn; 1985 Jun; 21(2):173-81. PubMed ID: 2417270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrin metabolism in patients with acute myocardial infarction during and after treatment with tissue-type plasminogen activator.
    Ring ME; Butman SM; Bruck DC; Feinberg WM; Corrigan JJ
    Thromb Haemost; 1988 Dec; 60(3):428-33. PubMed ID: 2976994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibrinopeptide A in urine from patients with venous thromboembolism, disseminated intravascular coagulation and rheumatoid arthritis--evidence for dephosphorylation and carboxyterminal degradation of the peptide by the kidney.
    Leeksma OC; Meijer-Huizinga F; Stoepman-van Dalen EA; van Aken WG; van Mourik JA
    Thromb Haemost; 1985 Dec; 54(4):792-8. PubMed ID: 4089813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis of septic pelvic thrombophlebitis by measurement of fibrinopeptide A.
    Weiner CP; Kwaan H; Duboe F
    Am J Perinatol; 1985 Apr; 2(2):93-5. PubMed ID: 4096764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of protease inhibitors on coagulation abnormalities in acute canine pancreatitis.
    Izquierdo R; Sandberg L; Squillaci G; Hoppensteadt D; Walenga J; Fareed J; Prinz R
    Am Surg; 1984 Jun; 50(6):317-23. PubMed ID: 6203448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma fibrinopeptide A and beta-thromboglobulin in patients with chest pain.
    Douglas JT; Lowe GD; Forbes CD; Prentice CR
    Thromb Haemost; 1983 Aug; 50(2):541-2. PubMed ID: 6195751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elastase mediated fibrinolysis in acute promyelocytic leukemia.
    Oudijk EJ; Nieuwenhuis HK; Bos R; Fijnheer R
    Thromb Haemost; 2000 Jun; 83(6):906-8. PubMed ID: 10896247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and performance characteristics of a competitive enzyme immunoassay for fibrinopeptide A.
    Amiral J; Walenga JM; Fareed J
    Semin Thromb Hemost; 1984 Oct; 10(4):228-42. PubMed ID: 6393350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Activity of the coagulation and fibrinolysis in non-insulin-dependent diabetes mellitus. In vivo study].
    Conti M; Marongiu F; Mameli G; Mamusa AM; Cambuli AB; Cossu E; Sorano GG; Biondi G; Cirillo R; Balestrieri A
    Recenti Prog Med; 1989 Jun; 80(6):297-9. PubMed ID: 2772395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative study of heparin responses in arterial and venous thromboembolism using molecular markers for thrombosis.
    Sobel M; Sternbergh WC; Marques D; Grimsdale AS
    Circulation; 1993 Nov; 88(5 Pt 2):II426-31. PubMed ID: 8222189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coagulation responses to heparin in the ischemic limb: assessment of thrombin and platelet activation during vascular surgery.
    Sobel M; Gervin CA; Qureshi DG; Greenfield LJ
    Circulation; 1987 Sep; 76(3 Pt 2):III8-13. PubMed ID: 2957118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurement of fibrinopeptide A in patients treated with phenprocoumon.
    Harenberg J; Haas R; Zimmermann R
    Thromb Haemost; 1981 Jun; 45(3):282-4. PubMed ID: 7281107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.